C
Cresco Labs Inc
CNSX:CL
Cresco Labs Inc
CNSX:CL
Price:
1.36
CAD
4.62%
Market Closed
Market Cap:
CA$714.8m
Relative Value
The Relative Value of one CL stock under the Base Case scenario is hidden CAD. Compared to the current market price of 1.36 CAD, Cresco Labs Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CL Relative Value
HIDDEN
Multiples Across Competitors
CL Competitors Multiples
Cresco Labs Inc Competitors
Cresco Labs Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
C
|
Cresco Labs Inc
CNSX:CL
|
683.3m CAD | 0.8 | -3.9 | 7.2 | 11.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
866.9B USD | 13.3 | 42 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.1B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218B GBP | 5 | 28.7 | 15.9 | 22.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.3B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.9B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117B USD | 2.4 | 16.6 | 7 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
